Search Results Search Sort by RelevanceMost Recent State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016; 18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016; 18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016; 18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022; E111-119. doi: 10.1001/amajethics.2022.111. Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022; 24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022; 24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022; 24(5):E361-367. doi: 10.1001/amajethics.2022.361. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022; 24(5):E368-375. doi: 10.1001/amajethics.2022.368. Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022; 24(5):E376-381. doi: 10.1001/amajethics.2022.376. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016; 18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016; 18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016; 18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.
Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022; E111-119. doi: 10.1001/amajethics.2022.111.
Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022; 24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022; 24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Should Clinicians Respond to Patient Interest in Dietary Supplements to Treat Serious Chronic Illness? Valerie Clinard, PharmD, APh and Jennifer D. Smith, PharmD, BCACP, BC-ADM, CDCES Consumption of over-the-counter vitamins, minerals, and herbals is widespread, but clinicians lack critical information about their use. AMA J Ethics. 2022; 24(5):E361-367. doi: 10.1001/amajethics.2022.361.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022; 24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Case and Commentary May 2022 Do You Know How to Assess Risks Posed by Over-the-Counter Vitamin A Supplements? Dina H. Zamil, Emily K. Burns, Ariadna Perez-Sanchez, MD, and Rajani Katta, MD Label analysis is key to educating patients about risks of vitamin A-containing supplements. AMA J Ethics. 2022; 24(5):E376-381. doi: 10.1001/amajethics.2022.376.